Listed by the USPTO as INAM, SAHAR
Tech Center 1600 • Art Units: 1600 1622
This examiner grants 100% of resolved cases
INAM, SAHAR handles matters in Technology Center 1600 and art unit 1600. The profile contains 2 resolved cases, and the allowance rate is 100.0%. The median days to allowance are 986. The small resolved-case base makes the outcome metric a limited record, while the timing figure supplies additional context for prosecution planning.
The interview lift is 0.0%, so the available data does not associate interviews with an uplift in this record. The listed companies are Revolution Medicines Inc., Antecip Bioventures Ii LLC, and University of Florida Research Foundation Inc. The listed firms are Clark+Elbing LLP, Clark+Elbing LLP - Revolution Medicines, Inc., and K&L Gates LLP-Boston.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18874975 | THIAZOLIDINEDIONES FOR THE TREATMENT OF MUSCULAR DYSTROPHIES | Non-Final OA | University of Florida Research Foundation, Incorporated |
| 18572110 | Aminopyridine-based MTA-Cooperative PRMT5 Inhibitors | Non-Final OA | Mirati Therapeutics, Inc. |
| 17780786 | TREATMENT OF HEPATITIS B VIRUS (HBV) INFECTION | Final Rejection | UCL BUSINESS LTD |
| 18845317 | SUBSTITUTED IMIDAZO[1,5-A]PYRIDINE N-HETEROCYCLIC CARBENE (NHC) LIGANDS, CATALYST COMPLEXES THEREOF, AND METHODS USING SAME | Non-Final OA | Rutgers, The State University of New Jersey |
| 18805212 | PROLYL HYDROXYLASE DOMAIN INHIBITOR FOR TREATING HEMORRHAGIC OR BURN SHOCK | Non-Final OA | THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy100.0% of resolved applications examined by Sahar Inam were allowed (2 resolved cases), compared with 36.5% across Art Unit 1600 over the last five years.
This examiner's interview lift is +0.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Sahar Inam took 986 days on average from filing to allowance.
Sahar Inam examines applications in Art Unit 1600 in Tech Center 1600 (Biotechnology & Pharmaceuticals).